Cytokines in systemic lupus erythematosus, London, UK.
The meeting consisted of 11 talks that illustrated the complexity of the pathogenetic mechanisms underlying systemic lupus erythematosus and aimed to identify ways in which cytokine modulation might affect those mechanisms. The evidence relating to the involvement of tumour necrosis factor-alpha, interleukin-10 and BLyS in this disease was discussed in particular detail. A final discussion explored the possible ways in which cytokine modulation might lead to new methods of treating systemic lupus erythematosus in the future.
Rahman
Anisur
A
Centre for Rheumatology, Department of Medicine, University College London, London, UK. anisur.rahman@ucl.ac.uk
D000818:Animals; D001402:B-Lymphocytes / Q000187:drug effects; D016207:Cytokines / Q000502:physiology*; D006801:Humans; D016753:Interleukin-10 / Q000502:physiology; D008131:London; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000276:immunology*; D051379:Mice; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D016207:Cytokines; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10